Bile Acid Malabsorption: Symptoms, Diet, and Treatment Guide

Bile Acid Malabsorption: Symptoms, Diet, and Treatment Guide

By Dr. Onikepe Adegbola, MD PhD — Johns Hopkins-trained physician-scientist and founder of Casa de Sante

What Is Bile Acid Malabsorption?

Bile acids are produced by your liver, stored in the gallbladder, and released into the small intestine after you eat — particularly after fatty meals. Their job is to emulsify dietary fats so they can be absorbed. Normally, approximately 95% of bile acids are reabsorbed in the terminal ileum (the last part of the small intestine) and recycled back to the liver. This is called the enterohepatic circulation.

In bile acid malabsorption, this recycling system fails. Excess bile acids spill into the colon, where they stimulate water and electrolyte secretion, accelerate colonic motility, and cause the signature symptom: chronic, watery, urgent diarrhea.

What makes BAM clinically important — and frustrating — is how often it is missed. A meta-analysis published in Alimentary Pharmacology & Therapeutics found that approximately 28% of patients diagnosed with IBS-D (diarrhea-predominant IBS) actually had bile acid malabsorption as the primary cause of their symptoms. That means nearly one in three IBS-D patients may have an identifiable, treatable cause that is being overlooked.

Types of Bile Acid Malabsorption

BAM is classified into three types based on the underlying cause:

Type 1: Ileal Disease or Resection

Damage to or removal of the terminal ileum disrupts the bile acid reabsorption site. Common causes include Crohn's disease affecting the ileum, ileal resection surgery, and radiation enteritis. This is the best-understood and most "textbook" form.

Type 2: Primary (Idiopathic)

The most common type and the most frequently missed. There is no structural ileal disease — instead, the liver overproduces bile acids beyond the ileum's reabsorption capacity. This overproduction is linked to reduced levels of fibroblast growth factor 19 (FGF19), a hormone that normally signals the liver to slow bile acid synthesis. This is the type most often misdiagnosed as IBS-D.

Type 3: Secondary to Other Conditions

Associated with cholecystectomy (gallbladder removal — bile now continuously drips into the intestine rather than being released in controlled bursts), celiac disease, chronic pancreatitis, small intestinal bacterial overgrowth (SIBO), and medications including metformin.

Symptoms: How to Recognize BAM

The clinical presentation typically includes:

• Chronic watery diarrhea — the cardinal symptom. Stools are often yellow-green or orange-tinged from bile pigments
• Urgency — often severe, with fecal incontinence in some patients
• Diarrhea worse after fatty meals — fat triggers bile acid release
• Nocturnal diarrhea — waking at night with urgent bowel movements (this is unusual in IBS and should raise suspicion for BAM)
• Bloating and cramping — colonic irritation from bile acids
• Steatorrhea — fatty, greasy, foul-smelling stools if fat malabsorption is also present
• Perianal irritation — bile acids are caustic and irritate perianal skin

Diagnosis: The Challenge

SeHCAT Test (Gold Standard — But Not Available in the US)

The selenium-75 homocholic acid taurine (SeHCAT) test involves swallowing a capsule containing a radiolabeled synthetic bile acid and measuring retention at 7 days. Retention below 15% indicates mild BAM, below 10% moderate, and below 5% severe. This test is widely available in the UK and Europe but unfortunately not approved in the United States.

Alternatives Available in the US

• Empiric trial of bile acid sequestrant — Many gastroenterologists use a therapeutic trial of cholestyramine or colesevelam as a diagnostic test. If symptoms significantly improve within 2-4 weeks, BAM is likely the diagnosis. This pragmatic approach is endorsed by the American Gastroenterological Association.
• Serum C4 (7-alpha-hydroxy-4-cholesten-3-one) — A blood test that measures a bile acid synthesis intermediate. Elevated levels suggest overproduction (Type 2 BAM). Available at Quest Diagnostics and other major labs.
• Fecal bile acid measurement — A 48-hour stool collection measuring total fecal bile acids. More than 2,337 micromoles per 48 hours suggests BAM. This test is cumbersome but definitive.
• Serum FGF19 — Low levels support the diagnosis of Type 2 BAM. Not yet widely standardized for clinical use.

Treatment: Highly Effective When Diagnosed

1. Bile Acid Sequestrants (First-Line)

These medications bind excess bile acids in the intestinal lumen, preventing them from irritating the colon:

• Cholestyramine (Questran) — The classic first-line treatment. A powder mixed with water or juice. Start with 4g once daily and titrate up to 4g three times daily as needed. The main barrier is taste and texture — many patients find it unpalatable.
• Colesevelam (Welchol) — Available in tablet form, much easier to take than cholestyramine. Start with 625mg twice daily. Generally better tolerated and my preferred starting agent for this reason.
• Colestipol (Colestid) — Available as tablets or granules. An alternative if the other two are not tolerated.

Important medication interaction note: Bile acid sequestrants bind many other medications and reduce their absorption. Take all other medications at least 1 hour before or 4-6 hours after taking a sequestrant.

2. Dietary Modification

A low-fat diet reduces the stimulus for bile acid release:

• Limit total daily fat to 40-50g (approximately 20% of calories)
• Avoid fried foods, high-fat meats, cream-based sauces, and excessive oils
• Distribute fat intake evenly across meals rather than consuming large amounts at one meal
• Support fat digestion with Casa de Sante Digestive Enzymes which includes lipase to help break down dietary fats

3. Gut Microbiome Support

The gut microbiome plays a significant role in bile acid metabolism. Certain bacteria convert primary bile acids to secondary bile acids, and microbiome composition influences the severity of BAM symptoms. Casa de Sante Synbiotic provides targeted probiotic strains that support healthy bile acid metabolism alongside prebiotic fiber for microbiome diversity.

4. Treat the Underlying Cause

• Crohn's disease — optimize IBD treatment to reduce ileal inflammation
• SIBO — treat with appropriate antibiotics
• Celiac disease — strict gluten-free diet
• Post-cholecystectomy — dietary modification and sequestrants as needed

Frequently Asked Questions

How common is diarrhea after gallbladder removal?

Post-cholecystectomy diarrhea affects approximately 10-20% of patients and is primarily caused by bile acid malabsorption (Type 3 BAM). Without the gallbladder to store and release bile in a controlled manner, bile continuously drips into the intestine, overwhelming the ileum's reabsorption capacity. Most patients respond well to colesevelam or cholestyramine.

Can bile acid malabsorption cause weight loss?

Yes. Chronic diarrhea with fat malabsorption can lead to both caloric and micronutrient losses. Fat-soluble vitamins (A, D, E, K) may become deficient. If you have BAM with weight loss, ensure these vitamins are monitored and supplemented as needed.

Is BAM the same as IBS-D?

No, though they are frequently confused. BAM is a specific, identifiable condition with a defined mechanism and targeted treatment. IBS-D is a functional disorder diagnosed by symptom criteria after excluding organic causes — BAM should be one of the conditions excluded before diagnosing IBS-D, but often is not.

Can you develop BAM from antibiotics?

Antibiotics can disrupt the gut microbiome, which plays a role in bile acid metabolism. Some patients develop diarrhea after antibiotics that persists and may represent BAM triggered by microbiome disruption. If post-antibiotic diarrhea persists beyond 4-6 weeks, evaluation for BAM and C. difficile is warranted.

How long do you need to take bile acid sequestrants?

For Type 2 (primary) BAM, treatment is typically long-term or indefinite, since the underlying overproduction persists. For Type 1 (ileal disease), treatment duration depends on the activity of the underlying condition. For Type 3 (post-cholecystectomy), many patients need ongoing treatment, though some gradually improve as the body adapts.